Anaptysbio ANAB
NASDAQ ANAB
$47.94 +2.51 (+5.52%)
At close: Oct 21, 2026 · 4:00 PM EDT

Anaptysbio (ANAB) Long-Term Debt Repayments (2018 - 2020)

Updated

Anaptysbio's Long-Term Debt Repayments came in at $1.38 million for FY2020, down 81.7% from $7.5 million in FY2019.

Analysis

Anaptysbio (ANAB) Long-Term Debt Repayments (2018 - 2020) Analysis & Trends

  • Per Business Quant, earlier years put Long-Term Debt Repayments at $7.5 million in FY2019 (+9.1%) and $6.88 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Anaptysbio 1.37 Bn 260.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 1.38 Mn
Dec 31, 2019 1.88 Mn
Sep 30, 2019 1.88 Mn
Jun 30, 2019 1.88 Mn
Mar 31, 2019 1.88 Mn
Dec 31, 2018 1.88 Mn
Sep 30, 2018 1.88 Mn
Jun 30, 2018 1.88 Mn
Mar 31, 2018 1.25 Mn
API Access

Anaptysbio Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ANAB&period=max&api_key=YOUR_API_KEY